Contributor Dr
In postmenopausal women with diabetes, ApoJ levels dropped by 26.3% and 19.4% after 8 and 12 weeks of exercise, respectively, showing a strong correlation with improved IR [276]
In the context of hepatic IR associated with non-alcoholic fatty liver disease (NAFLD), this molecular pathway becomes dysregulated, leading to impaired suppression of hepatic gluconeogenesis
Suggested table of clinical case studies (to include in article): columns for patient phenotype (age, BMI, diagnosis), peptide used (dose, duration), metabolic outcomes (weight change, HOMA-IR), reproductive outcomes (ovulation, oocyte yield, pregnancy), adverse events, and follow-up duration, such as PCOS, obesity-associated anovulation, poor ovarian response, and metabolic syndrome
Research shows that people on GLP-1 medications can lose between 15% and 25% of their body weight after a year
Injections are given once a week every 7 days